Scott discusses the unpredictable nature of investments, sharing his experience with a significant financial downturn in one of his ventures. He highlights the costly and complex process of obtaining FDA approval, emphasizing the importance of thorough research and regulatory compliance. Despite the hurdles faced in a challenging market, Scott reflects on the resilience required to navigate these turbulent times.
